XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Operating expenses:        
Research and development $ 8,683 $ 2,310 $ 26,727 $ 2,733
General and administrative 5,919 1,454 14,776 2,444
Total operating expenses 14,602 3,764 41,503 5,177
Loss from operations (14,602) (3,764) (41,503) (5,177)
Other income (expense), net:        
Other income (expense), net 10   14  
Related party convertible note interest expense       (40)
Change in fair value of the Series A redeemable convertible preferred stock tranche liability   380 (10,341) 380
Total other income (expense), net 10 380 (10,327) 340
Net loss and comprehensive loss $ (14,592) $ (3,384) $ (51,830) $ (4,837)
Net loss per share attributable to common stockholders—basic and diluted $ (0.28) $ (1.00) $ (2.51) $ (2.53)
Weighted-average shares used in computing net loss per share— basic and diluted 52,769,916 3,382,118 20,668,560 1,908,759